Annual Report

Overview

The report describes the company’s acquisition of Yekaitai and transformation into pharmaceutical retail, attainment of its 10% GHG reduction target ahead of schedule, and Board-led ESG oversight with annual materiality assessment and reporting processes.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2023
Period: 1 April 2023 – 31 March 2024
Publication date: 28 June 2024
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services